RxDoctor Payments Data

Eric Thompson, DPM

Foot Surgery · Vernon, CTNPI 1942208202

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for foot surgery clinicians in CT, where the typical reported total is $962.

$553in general payments, 2019–2025

Across 20 payments — averaging $27.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$121
  • Misonix Inc$103
  • Stryker$85
  • GSK$57
  • Kerecis Limited$49
  • Mimedx Group, Inc.$36
  • plus $103 from 5 others

What the payments were for

  • Food & beverage$553100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$553 in reported general payments places this provider in the 35th percentile of 20 foot surgery providers in Connecticut.

See all foot surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$59,743
Medicare patients
219
Services billed
851

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefdinir13$378
Amoxicillin11$49

Paid to pharmacies, not to this prescriber.

Other foot surgery in Vernon

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →